Skip to main content

Table 1 Study characteristics of included studies

From: Surgical approaches for treatment of ureteropelvic junction obstruction – a systematic review and network meta-analysis

Author

Publication year

Design

Operative approaches

End points

Study size

Secondary UPJO

Uro-lithiasis

Country

Population

Mean age [years]

Percent female

Follow up [monts]

Baldwin et al. [25]

2003

retrospective

EP, LP, OP

operative success, operating time, estimated blood loss, transfusion, complications, length of stay, analgesia requirement

32

LP 44%, EP 33%, OP 43%

NA

USA

adult

44,4 and 37 and 42

NA

11,0 and 9,9 and 5,4

Bernie et al. [26]

2005

retrospective

LP, RP

operative success, operating time, estimated blood loss, complications, urinary leakage, length of stay

14

NA

NA

USA

adult

34 and 32

NA

24 and 10

Bird et al. [27]

2011

prospective

LP, RP

operative success, operating time, suturing time, estimated blood loss, conversion, complications, length of stay

172

13% overall

LP 16%, RP 30%

USA

adult

39,7+/−14,6

53

NA

Brooks et al. [28]

1995

retrospective

EP, LP, OP

operative success, operating time, transfusion, re-operation, complications, length of stay, time to return to normal activity, analgesia requirement

45

EP 23%, LP 8%, OP 18%

EP 1%, LP 0%, OP 9%

USA

adult

42 and 38,4 and 30,6

60

22,0 and 13,6 and 26,0

Calvert et al. [29]

2008

retrospective

LP, OP

operative success, operating time, conversion, complications, length of stay

100

OP 6%, LP 14%

NA

UK

adult

36,5

77

9 and 12

Chen et al. [30]

2016

retrospective

EP, LP, OP

operative success, operating time, estimated blood loss, conversion, complications, urinary leakage, length of stay

109

NA

NA

China

children and adult

32,8+/−15,6 and 30,9+/− 12,9 and 37,5+/− 12,0

39

51,9+/− 40,1

Danuser et al. [31]

2012

NA

LP, RP

operative success, operating time, conversion, complications, length of stay

82

NA

NA

Switzerland

NA

NA

NA

NA

Desai et al. [14]

2004

retrospective

EP, LP

operative success, operating time, re-operation, complications, length of stay

29

none

NA

USA and India

adult

38,6+/−16,1 and 38,9+/− 17

48

31,4+/− 12,6 and 20,0+/−14,0

Fahad [32]

2017

NA

LP, OP

operative success, operating time, conversion, re-operation, complications, urinary leakage, deaths, length of stay, time to return to normal activity, analgesia requirement

40

NA

NA

Iraq

children and adult

24

35

9

Garcia-Galisteo et al. [33]

2011

retrospective

LP, RP

operative success, operating time, suturing time, estimated blood loss, transfusion, complications, deaths, length of stay

50

NA

NA

Spain

children and adult

33,9

60

20,6 and 42,5

Han et al. [22]

2008

retrospective

EP, LP

operative success, operating time, transfusion, complications, length of stay, renal function

45

EP 31%, LP 13%

NA

Korea

adult

45,22 and 49,5 ± 13,6

47

15,2 and 14,3

Hanske et al. [20]

2015

retrospective

LP, OP

transfusion, re-operation, complications, deaths

593

NA

NA

USA

adult

median 48

57

1

Hemal et al. [34]

2010

retrospective

LP, RP

operative success, operating time, suturing time, estimated blood loss, conversion, re-operation, complications, length of stay, time to return to normal activity, analgesia requirement

60

NA

NA

India

children and adult

24,9 and 28,1

32

18

Klingler et al. [35]

2003

retrospective

LP, OP

operative success, re-operation, complications, pain, analgesia requirement

55

LP 8%, OP 0%

NA

Switzerland

adult

35,9+/−21,1 and 41,0+/−27,9

60

19,4+/−9,1 and 17,9+/−8,8

Link et al. [36]

2006

prospective

LP, RP

operating time, complications, urinary leakage

20

none

NA

USA

adult

46,5 and 38,0

65

5,6

Lucas et al. [16]

2012

retrospective

LP, RP

operative success, operating time, estimated blood loss, complications, urinary leakage

759

RP 27%, LP 24%

RP 18%, LP 12%

North America

NA

35

NA

11+/−13 and 15+/− 16

Memon et al. [37]

2016

retrospective

LP, OP

operative success, operating time, estimated blood loss, complications, length of stay

73

none

NA

Pakistan

adult

28 and 30

59

2,7+/−1,2

Mohammed [38]

2017

prospective

LP, OP

operative success, operating time, estimated blood loss, re-operation, length of stay

55

NA

NA

Germany

obese, NA

NA

NA

> 12

Olweny et al. [39]

2012

retrospective

LP, RP

operative success, operating time, estimated blood loss, conversion, complications, length of stay, analgesia requirement

20

none

NA

USA

adult

40,3 and 35,8

57

2,8 and 9,2

Pahwa et al. [40]

2014

pro- and retrospective

LP, OP, RP

operative success, operating time, estimated blood loss, complications, length of stay

90

none

NA

India

adult

31,4 and 34,4 and 32

33

32,0 and 18,0 and 13,5

Rivas et al. [15]

2015

retrospective

LP, OP

operative success, conversion, complications, deaths, length of stay

92

NA

LP 19%, OP 20%

Spain

adult

44,5 and 38,5

NA

45

Simforoosh et al. [41]

2004

prospective

LP, OP

operative success, operating time, transfusion, re-operation, complications, urinary leakage, length of stay

69

none

NA

Iran

children and adult

18,2 and 23,1

38

16,5 and 11,4

Umari et al. [42]

2011

retrospective

LP, OP

operative success, operating time, conversion, complications, length of stay

49

NA

LP 17%, OP 32%

Italy

children and adult

42

51

72,3 and 40,9

Wang et al. [43]

2013

retrospective

LP, OP

operative success, operating time, estimated blood loss, complications, urinary leakage, length of stay, analgesia requirement

172

NA

NA

China

children and adult

21 AND 25 years

34

32,7 AND 38,4 months

Weise and Winfield [44]

2006

prospective

LP, RP

operative success, operating time, estimated blood loss, transfusion, complications, length of stay

45

LP 7%, RP 0%

NA

USA

children and adult

26 and 24,5

59

6 and 10

Yanke et al. [21]

2008

retrospective

EP, LP, RP

operative success

273

EP 29%; LP 28%, RP 31%

NA

USA

adult

NA

61

20 and 20 and 19